DOI: https://dx.doi.org/10.18203/2349-3933.ijam20222404
Published: 2022-09-23

A neglected cause of anaemia: hereditary hemorrhagic telangiectasia

Sadhana Rajasekhar, Rameshwar R., Ramkumar M., Jagadeesan M., Magesh Kumar S.

Abstract


Hereditary hemorrhagic telangiectasia (HHT) or Osler-Weber-Rendu syndrome is an inherited disorder characterized by vascular dysplasias leading to hemorrhages. If affects approximately 1 in 10,000 Caucasian people. The most common presentation is chronic and recurrent epistaxis whereas bleeding from other sites can lead to life-threatening complications.


Keywords


HHT, Colonic polyp, Iron deficiency anemia

Full Text:

PDF

References


Lisa S. Hereditary Hemorrhagic Telangiectasia-NORD (National Organization for Rare Disorders).” NORD (National Organization for Rare Disorders). 2021. Available at: rarediseases.org. Accessed on May 10, 2022.

Amanzada A, Gwen-Jana T. A Case Report of a Patient with Hereditary Hemorrhagic Telangiectasia Treated Successively with Thalidomide and Bevacizumab-PMC. Case Rep Oncol. 2010;3(3):463-70.

Khan AR, Ahmad R, Salma W. A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report. Cureus. 2022;14(4):e24517.

Asfandyar M, Muskaan S. Hereditary haemorrhagic telangiectasia: A case report.” SAGE open Med Case Rep. 2021;9:2050313X211003076.

Kang B, Su-Kyeong H, Sujin C, Eun SK. Case Report of Juvenile Polyposis/Hereditary Hemorrhagic Telangiectasia Syndrome: First Report in Korea with a Novel Mutation in the SMAD4 Gene. Kang-Translational Pediatr. 2021;10(5):1369-76.

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome). Cedars-Sinai.” Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome). Cedars-Sinai. 2021. Available at: www.cedars-sinai.org. Accessed on May 10, 2022.

Athena K, Al-Samkari H, Kuter DJ. Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management from the Hematologist’s Perspective. Haematologica.” Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management from the Hematologist’s Perspective. Haematologica. 2018;103(9):1-5.

CDC. “Facts About Hereditary Hemorrhagic Telangiectasia (HHT). CDC. Centers for Disease Control and Prevention. 2022. Available at: www.cdc.gov. Accessed on May 10, 2022.

Iyer NK, Burke CA, Leach BH. SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia. Thorax. 2010;65:745-6.

McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011;13(7):607-16.

Fuchizaki U, Miyamori H, Kitagawa S, Kaneko S, Kobayashi K. Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Lancet. 2003;362(9394):1490-4.

Gallione CJ, Richards JA, Letteboer T. SMAD4 mutations found in unselected HHT patients. J Med Genet. 2006;43(10):793-7.